Question - Sudden Hearing Loss
AM-111 Granted Fast-Track Designation
Asked 9 years ago Jakob Hansen 480
Auris Medical's AM-111 drug candidate has been granted fast-track designation by the FDA. The drug which is developed for the treatment of acute sudden hearing loss is currently in phase-III trials. The intratympanic therapy is being investigated in two separate trial arms - the topline results from the first treatment arm are expected by the third quarter of 2017. Read the full news release via the link below.
http://www.nasdaq.com/press-release/auris-medical-receives-fda-fast-track-designation-for-am111-in-acute-sensorineural-hearing-loss-20170224-00441
Is Sudden Hearing Loss hereditary?
Is it easy to find a partner and/or maintain relationship when you have Sud...
Celebrities with Sudden Hearing Loss
Can people with Sudden Hearing Loss work? What kind of work can they perfor...
What is the prevalence of Sudden Hearing Loss?
ICD10 code of Sudden Hearing Loss and ICD9 code
How do I know if I have Sudden Hearing Loss?
